dc.description.abstract |
We investigated the antiarrhythmic effects of ischemic preconditioning (IPC) and postconditioning (PostC) by intracardiac electrocardiogram (ECG) and measured circulating microRNAs (miRs) that are related to cardiac conduction. Domestic pigs underwent 90-min. percutaneous occlusion of the mid left anterior coronary artery, followed by reperfusion. The animals were divided into three groups: acute myocardial infarction (AMI, n = 7), ischemic preconditioning-acute myocardial infarction (IPC-AMI) (n = 9), or AMI-PostC (n = 5). IPC was induced by three 5-min. episodes of repetitive ischemia/reperfusion cycles (rI/R) before AMI. PostC was induced by six 30-s rI/R immediately after induction of reperfusion 90 min after occlusion. Before the angiographic procedure, a NOGA endocardial mapping catheter was placed again the distal anterior ventricular endocardium to record the intracardiac electrogram (R-amplitude, ST-Elevation, ST-area under the curve (AUC), QRS width, and corrected QT time (QTc)) during the entire procedure. An arrhythmia score was calculated. Cardiac MRI was performed after one-month. IPC led to significantly lower ST-elevation, heart rate, and arrhythmia score during ischemia. PostC induced a rapid recovery of R-amplitude, decrease in QTc, and lower arrhythmia score during reperfusion. Slightly higher levels of miR-26 and miR-133 were observed in AMI compared to groups IPC-AMI and AMI-PostC. Significantly lower levels of miR-1, miR-208, and miR-328 were measured in the AMI-PostC group as compared to animals in group AMI and IPC-AMI. The arrhythmia score was not significantly associated with miRNA plasma levels. Cardiac MRI showed significantly smaller infarct size in the IPC-AMI group when compared to the AMI and AMI-PostC groups. Thus, IPC led to better left ventricular ejection fraction at one-month and it exerted antiarrhythmic effects during ischemia, whereas PostC exhibited antiarrhythmic properties after reperfusion, with significant downregulaton of ischemia-related miRNAs. |
|
dc.mtmt.swordnote |
Department of InternalMedicine II, Division of Cardiology, Medical University of Vienna, Vienna, 1090, Austria
Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, 1089, Hungary
Pharmahungary Group, Szeged, 6722, Hungary
National Heart Centre Singapore, Singapore, 169609, Singapore
Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore, 169857, Singapore
The Hatter Cardiovascular Institute, University College London, London, WC1E 6HX, United Kingdom
Barts Heart Centre, St Bartholomew’s Hospital, London, EC1A 7BE, United Kingdom
The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, W1T 7DN, United Kingdom
Yong Loo Lin School of Medicine, National University Singapore, Singapore, 117597, Singapore
Institute for Regenerative Medicine (IREM), University of Zurich, Zurich, 8952, Switzerland
Department of Cardiovascular Surgery, Charité Universitätsmedizin Berlin, Berlin, 10117, Germany
Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, 13353, Germany
Center for MR-Research, University Children’s Hospital Zurich, Zürich, 8032, Switzerland
Cited By :1
Export Date: 5 September 2019
Correspondence Address: Gyöngyösi, M.; Department of InternalMedicine II, Division of Cardiology, Medical University of ViennaAustria; email: mariann.gyongyosi@meduniwien.ac.at |
|